Optimal Erythrocyte Ribavirin Level to Reduce the Risk of Anemia and Obtain an Early Virological Response in Patients with Chronic Hepatitis C Caused by Genotype 1b Infection
Hepatitis Research and Treatment · 2010
DOI: 10.1155/2010/495928 ↗Abstract
Aims . To determine whether the erythrocyte phosphorylated ribavirin (RBV) level might be a useful index of EVR and risk of anemia and to determine the optimal dose of RBV in 24 patients with hepatitis C with pegylated interferon and RBV. Methodology . The RBV level was measured by a high-performance liquid chromatography. Results and Conclusion . In patients aged 50 years or over, a negative correlation (, ) was observed between the RBV level at week 2 and rate of Hb reduction () at week 4. The at week 4 was significantly greater in patients with RBV levels of ≥800 ( %) than in patients with RBV levels
EUVIMED